NYSE - Delayed Quote • USD
Haemonetics Corporation (HAE)
At close: May 17 at 4:00 PM EDT
After hours: May 17 at 6:42 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | 1 | 1.09 | 4.6 | 5.44 |
| Low Estimate | 0.95 | 1.05 | 4.55 | 5.12 |
| High Estimate | 1.05 | 1.14 | 4.62 | 5.96 |
| Year Ago EPS | 1.05 | 0.99 | 3.96 | 4.6 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 7 | 7 |
| Avg. Estimate | 335.38M | 345.76M | 1.4B | 1.48B |
| Low Estimate | 329.16M | 339.5M | 1.39B | 1.43B |
| High Estimate | 345.21M | 351.97M | 1.41B | 1.54B |
| Year Ago Sales | -- | -- | 1.31B | 1.4B |
| Sales Growth (year/est) | -- | -- | 7.00% | 5.30% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.73 | 0.89 | 0.94 | 0.89 |
| EPS Actual | 1.05 | 0.99 | 1.04 | 0.9 |
| Difference | 0.32 | 0.1 | 0.1 | 0.01 |
| Surprise % | 43.80% | 11.20% | 10.60% | 1.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 1 | 1.09 | 4.6 | 5.44 |
| 7 Days Ago | 1.03 | 1.08 | 4.43 | 5 |
| 30 Days Ago | 1.03 | 1.08 | 4.4 | 4.88 |
| 60 Days Ago | 1.03 | 1.08 | 4.41 | 4.89 |
| 90 Days Ago | 1.03 | 1.08 | 4.41 | 4.89 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 2 | 5 | 5 |
| Up Last 30 Days | 2 | 2 | 6 | 6 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 4 | 1 | -- | -- |
Growth Estimates
| CURRENCY IN USD | HAE | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -4.80% | -- | -- | 8.00% |
| Next Qtr. | 10.10% | -- | -- | 12.40% |
| Current Year | 16.20% | -- | -- | 5.60% |
| Next Year | 18.30% | -- | -- | 13.00% |
| Next 5 Years (per annum) | 12.00% | -- | -- | 11.14% |
| Past 5 Years (per annum) | 6.84% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | JMP Securities: Market Outperform to Market Outperform | 5/10/2024 |
| Maintains | Barrington Research: Outperform to Outperform | 5/10/2024 |
| Reiterates | Needham: Hold | 5/10/2024 |
| Maintains | Barrington Research: Outperform to Outperform | 4/12/2024 |
| Reiterates | Barrington Research: Outperform to Outperform | 2/13/2024 |
| Maintains | Barrington Research: Outperform to Outperform | 11/3/2023 |
Related Tickers
MMSI Merit Medical Systems, Inc.
81.89
-0.45%
ICUI ICU Medical, Inc.
103.99
-2.15%
TFX Teleflex Incorporated
217.64
-0.43%
COO The Cooper Companies, Inc.
97.31
-0.60%
HOCPY HOYA Corporation
121.65
-0.89%
RMD ResMed Inc.
218.57
-0.64%
RGEN Repligen Corporation
171.94
+0.53%
LMAT LeMaitre Vascular, Inc.
78.45
+0.99%
ATRI Atrion Corporation
465.25
+2.06%
ATRC AtriCure, Inc.
23.14
+2.25%